Overview

• FDA inspectors found issues with record keeping and quality controls for animal experiments at Neuralink's California facility.
• Neuralink was cleared for human trials of its brain implant technology despite these issues.
• The brain implant aims to help patients with paralysis communicate using thoughts to move a computer device.
• Concerns were raised about potential animal-welfare violations at Neuralink, but the FDA has not designated the issues as significant enough to prompt action.
• Neuralink's first human trial participant has reportedly made a full recovery, with the company continuing to monitor safety.